Molecular imaging and therapy uses small amounts of radioactive substances to detect or treat disease. At Fred Hutch Cancer Center, our molecular imaging and therapy specialists are part of nearly ...

This versatile and scalable imaging modality has now shown potential for molecular imaging, which enables visualization of biological processes with systemically introduced contrast agents.

Two new open-source tools are set to make fluorescence lifetime imaging microscopy—or FLIM—faster, simpler and more ...

Life Molecular Imaging Secures Funding from the Alzheimer's Drug Discovery Foundation (ADDF) to Further Investigate [18F]F-DED PET in Alzheimer's Neuroinflammation. News provided by.

Long Stokes shift SOD for biomedical fluorescence imaging. (A) Chemical structure, molecular weight, max absorption, and emission wavelength, Stokes shift of typical commercial fluorescent dyes.

Reston, VA (August 20, 2024) -- A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory ...

Molecular Instruments® (www.molecularinstruments.com) develops and synthesizes molecular kits powered by the breakthrough HCR™ imaging platform for applications in academic research, drug ...

Enhances Lantheus’ growth profile with Neuraceq®, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s Disease Advances ...

The Prostate Cancer Foundation (PCF) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced a collaboration that will provide funding and su ...

(RTTNews) - Lantheus Holdings Inc. (LNTH), a radiopharmaceutical-focused company, announced Monday a definitive agreement to acquire Life Molecular Imaging Ltd., a unit of Life Healthcare Group ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting hepatocellular carcinoma (HCC), including tumors smaller than one ...